World’s first once-weekly insulin launched in India
Pharmaceutical company Novo Nordisk has introduced Awiqli (insulin icodec) in India, describing it as the world’s first once-weekly basal insulin for adults with Type 1 and Type 2 diabetes. The treatment reduces the frequency of basal insulin injections from daily administration to a single weekly dose, potentially lowering the number of injections required each year. According to the company, delayed… Continue reading "World’s first once-weekly insulin launched in India"